In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
Copyright policy )In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
Background Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19 compared to non-IS patients is not known. The aim of this study was to evaluate the clinical characteristics and outcome of IS patients hospitalized with COVID-19 compared to non-IS patients. Methods We designed a retrospective cohort study. We included all patients hospitalized with laboratory-confirmed COVID-19 from the SEMI-COVID-19 Registry, a large multicentre national cohort in Spain, from March 27 th until June 19 th , 2020. We used multivariable logistic regression to assess the adjusted odds ratios (aOR) of in-hospital death among IS compared to non-IS patients. Results Among 13 206 included patients, 2 111 (16.0%) were IS. A total of 166 (1.3%) patients had solid organ (SO) transplant, 1081 (8.2%) had SO neoplasia, 332 (2.5%) had hematologic neoplasia, and 570 (4.3%), 183 (1.4%) and 394 (3.0%) were receiving systemic steroids, biological treatments, and immunosuppressors, respectively. Compared to non-IS patients, the aOR (95% CI) for in-hospital death was 1.60 (1.43–1.79) for all IS patients, 1.39 (1.18–1.63) for patients with SO cancer, 2.31 (1.76–3.03) for patients with haematological cancer and 3.12 (2.23–4.36) for patients with SO transplant. The aOR (95% CI) for death for patients who were receiving systemic steroids, biological treatments and immunosuppressors compared to non-IS patients were 2.16 (1.80–2.61), 1.97 (1.33–2.91) and 2.06 (1.64–2.60), respectively. IS patients had a higher odds than non-IS patients of in-hospital acute respiratory distress syndrome, heart failure, myocarditis, thromboembolic disease and multiorgan failure. Conclusions IS patients hospitalized with COVID-19 have a higher odds of in-hospital complications and death compared to non-IS patients.
Male, Hospital mortality, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Patient Care::Hospitalization, España, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Mortalidad hospitalaria, Cohort Studies, Odds Ratio, Medical Subject Headings::Phenomena and Processes::Immune System Phenomena::Immunocompromised Host, Hospital Mortality, Registries, Hematologic neoplasms, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Hospital Mortality, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis, Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Heart Failure, Aged, 80 and over, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical::Logistic Models, Diagnóstico, Q, R, Insuficiencia cardíaca, Odds ratio, Middle Aged, Prognosis, Insuficiencia multiorgánica, Virus, Medical Subject Headings::Check Tags::Male, Hospitalization, Myocarditis, Hematologic Neoplasms, Medicine, Miocarditis, Steroids, Female, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Registries, Coronavirus Infections, Research Article, Science, Multiple Organ Failure, 610, Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Cardiomyopathies::Myocarditis, Heart failure, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunosuppression, Oportunidad relativa, Inmunosupresión, Immunocompromised Host, Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Hematologic Neoplasms, Medical Subject Headings::Persons::Persons::Age Groups::Adult::Middle Aged, 616, Humans, Medical Subject Headings::Persons::Persons::Age Groups::Adult::Aged::Aged, 80 and over, Aged, Retrospective Studies, Heart Failure, Medical Subject Headings::Diseases::Respiratory Tract Diseases::Lung Diseases::Respiratory Distress Syndrome, Adult, Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids, SARS-CoV-2, Respiratory Distress Syndrome, Adult, COVID-19, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Geographical Locations::Geographic Locations::Europe::Spain, Huésped Inmunocomprometido, Multiple organ failure, Logistic Models, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies, Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Shock::Multiple Organ Failure, Medical Subject Headings::Persons::Persons::Age Groups::Adult::Aged, Spain, Mortalidad, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Odds Ratio, Immunosuppression, Neoplasias hematológicas
Male, Hospital mortality, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Patient Care::Hospitalization, España, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Mortalidad hospitalaria, Cohort Studies, Odds Ratio, Medical Subject Headings::Phenomena and Processes::Immune System Phenomena::Immunocompromised Host, Hospital Mortality, Registries, Hematologic neoplasms, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Hospital Mortality, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis, Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Heart Failure, Aged, 80 and over, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical::Logistic Models, Diagnóstico, Q, R, Insuficiencia cardíaca, Odds ratio, Middle Aged, Prognosis, Insuficiencia multiorgánica, Virus, Medical Subject Headings::Check Tags::Male, Hospitalization, Myocarditis, Hematologic Neoplasms, Medicine, Miocarditis, Steroids, Female, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Registries, Coronavirus Infections, Research Article, Science, Multiple Organ Failure, 610, Medical Subject Headings::Diseases::Cardiovascular Diseases::Heart Diseases::Cardiomyopathies::Myocarditis, Heart failure, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunosuppression, Oportunidad relativa, Inmunosupresión, Immunocompromised Host, Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Hematologic Neoplasms, Medical Subject Headings::Persons::Persons::Age Groups::Adult::Middle Aged, 616, Humans, Medical Subject Headings::Persons::Persons::Age Groups::Adult::Aged::Aged, 80 and over, Aged, Retrospective Studies, Heart Failure, Medical Subject Headings::Diseases::Respiratory Tract Diseases::Lung Diseases::Respiratory Distress Syndrome, Adult, Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids, SARS-CoV-2, Respiratory Distress Syndrome, Adult, COVID-19, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Geographical Locations::Geographic Locations::Europe::Spain, Huésped Inmunocomprometido, Multiple organ failure, Logistic Models, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies, Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Shock::Multiple Organ Failure, Medical Subject Headings::Persons::Persons::Age Groups::Adult::Aged, Spain, Mortalidad, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Odds Ratio, Immunosuppression, Neoplasias hematológicas
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).50 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!